Literature DB >> 6603517

Transient hypogammaglobulinemia in the adult. Functional assessment of T and B lymphocytes.

M C Garcia Rodriguez, E G de la Concha, G Fontán, D Pascual-Salcedo, J Fernandez, J A Ojeda, A Garcia Diaz.   

Abstract

The woman described suffered from a pruritic erythematous rash, edema, malaise and fever which appeared during Tegretol therapy. The patient was shown to have a severe hypogammaglobulinemia with absence of circulating B lymphocytes, but normal cell-mediated immunity. There was an absence of in vitro immunoglobulin production by the patient's cells, but this was not due to excessive T-suppressor activity or lack of T-cell help. When drug administration was stopped the edema and rash began to recede promptly, and a few months later her serum immunoglobulin levels, antibody titers and in vitro immunoglobulin production became normal. This transient, probably drug-dependent case of hypogammaglobulinemia, added to three previously reported cases, stresses the need of considering non-conventional immunosuppressive drugs as a potential-etiological agent in acquired hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603517

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  4 in total

1.  IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.

Authors:  Zenichiro Kato; Mizuho Watanabe; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2003-01-25       Impact factor: 3.183

2.  Antibody deficiency associated with carbamazepine.

Authors:  G Hayman; A Bansal
Journal:  BMJ       Date:  2002-11-23

3.  Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia.

Authors:  Claire M Rice; Sarah L Johnston; David J Unsworth; Stuart C Glover; Matthew Donati; Shelley A Renowden; John Holloway; Sam D Lhatoo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

4.  Hypogammaglobulinaemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment.

Authors:  G P Spickett; M M Gompels; P W Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.